Imatinib Mesylate

Added: Dec 02, 2016 8:53 am PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) VA797P-17-R-0010 for an unrestricted procurement for Imatinib Mesylate Tablets, for the Department of Veterans Affairs (VA), Department of Defense (DOD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The contract items will be distributed through the VA s and DOD s respective Pharmaceutical Prime Vendor Programs. Solicitation # VA797P-17-R-0010 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about December 21, 2016, with a tentative closing date of January 4, 2017. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at the following URL: http://www.fedbizopps.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check this URL for any changes to this solicitation. Offers will be considered technically acceptable if the meet the following criteria: 1) NDC must be unique to the offeror, 2) Drug must be FDA approved, 3) Manufacturing facility must have an acceptable current Good Manufacturing Practices rating by FDA. 4) Offeror must meet the estimated annual requirements as listed below. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Christine Edakkunnath. Questions can be e-mailed to: christine.edakkunnath@va.gov.



The estimated annual requirements are as follows:

Description Size Estimated Annual Requirements

(Bottles) (Bottles)

Imatinib Mesylate 100 MG Tab 90 8,215

Imatinib Mesylate 400 MG Tab 30 27,823